Sickle Cell Disease Drug Market Report

Japan Sickle Cell Disease Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • POSTDATE：Mar 19, 2020
  • PAGES：158
  • REPORT CODE：GMM512791
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Sickle Cell Disease Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Sickle Cell Disease Drug market. Detailed analysis of key players, along with key growth strategies adopted by Sickle Cell Disease Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Bristol-Myers Squibb Co

    • Bioverativ Inc

    • CSL Ltd

    • Calimmune Inc

    • Annexin Pharmaceuticals AB

    • Bio Products Laboratory Ltd

    • Gamida Cell Ltd

    • Angiocrine Bioscience Inc

    • Errant Gene Therapeutics LLC

    • ArQule Inc

    • CRISPR Therapeutics

    • Daiichi Sankyo Co Ltd

    • Acceleron Pharma Inc

    • Addmedica SAS

    • Global Blood Therapeutics Inc

    • bluebird bio Inc

    • Editas Medicine Inc

    • Gilead Sciences Inc

    • Genethon SA

    By Type:

    • ARQ-092

    • BIVV-003

    • CAL-H

    • CTX-001

    • DRX-194

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Sickle Cell Disease Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Sickle Cell Disease Drug Market Size and Growth Rate of ARQ-092 from 2014 to 2026

      • 1.3.2 Japan Sickle Cell Disease Drug Market Size and Growth Rate of BIVV-003 from 2014 to 2026

      • 1.3.3 Japan Sickle Cell Disease Drug Market Size and Growth Rate of CAL-H from 2014 to 2026

      • 1.3.4 Japan Sickle Cell Disease Drug Market Size and Growth Rate of CTX-001 from 2014 to 2026

      • 1.3.5 Japan Sickle Cell Disease Drug Market Size and Growth Rate of DRX-194 from 2014 to 2026

      • 1.3.6 Japan Sickle Cell Disease Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Sickle Cell Disease Drug Market Size and Growth Rate of Hospital from 2014 to 2026

      • 1.4.2 Japan Sickle Cell Disease Drug Market Size and Growth Rate of Clinic from 2014 to 2026

      • 1.4.3 Japan Sickle Cell Disease Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Sickle Cell Disease Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Sickle Cell Disease Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of ARQ-092

      • 3.4.2 Market Size and Growth Rate of BIVV-003

      • 3.4.3 Market Size and Growth Rate of CAL-H

      • 3.4.4 Market Size and Growth Rate of CTX-001

      • 3.4.5 Market Size and Growth Rate of DRX-194

      • 3.4.6 Market Size and Growth Rate of Others

    4 Segmentation of Sickle Cell Disease Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Sickle Cell Disease Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Sickle Cell Disease Drug in Hospital

      • 4.4.2 Market Size and Growth Rate of Sickle Cell Disease Drug in Clinic

      • 4.4.3 Market Size and Growth Rate of Sickle Cell Disease Drug in Others

    5 Market Analysis by Regions

    • 5.1 Japan Sickle Cell Disease Drug Production Analysis by Regions

    • 5.2 Japan Sickle Cell Disease Drug Consumption Analysis by Regions

    6 Hokkaido Sickle Cell Disease Drug Landscape Analysis

    • 6.1 Hokkaido Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    7 Tohoku Sickle Cell Disease Drug Landscape Analysis

    • 7.1 Tohoku Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    8 Kanto Sickle Cell Disease Drug Landscape Analysis

    • 8.1 Kanto Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 8.2 Kanto Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    9 Chubu Sickle Cell Disease Drug Landscape Analysis

    • 9.1 Chubu Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 9.2 Chubu Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    10 Kinki Sickle Cell Disease Drug Landscape Analysis

    • 10.1 Kinki Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 10.2 Kinki Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    11 Chugoku Sickle Cell Disease Drug Landscape Analysis

    • 11.1 Chugoku Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    12 Shikoku Sickle Cell Disease Drug Landscape Analysis

    • 12.1 Shikoku Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    13 Kyushu Sickle Cell Disease Drug Landscape Analysis

    • 13.1 Kyushu Sickle Cell Disease Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Sickle Cell Disease Drug Landscape Analysis by Major End-Users

    14 Major Players Profiles

    • 14.1 Bristol-Myers Squibb Co

      • 14.1.1 Bristol-Myers Squibb Co Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Bioverativ Inc

      • 14.2.1 Bioverativ Inc Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 CSL Ltd

      • 14.3.1 CSL Ltd Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Calimmune Inc

      • 14.4.1 Calimmune Inc Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Annexin Pharmaceuticals AB

      • 14.5.1 Annexin Pharmaceuticals AB Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Bio Products Laboratory Ltd

      • 14.6.1 Bio Products Laboratory Ltd Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Gamida Cell Ltd

      • 14.7.1 Gamida Cell Ltd Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Angiocrine Bioscience Inc

      • 14.8.1 Angiocrine Bioscience Inc Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 Errant Gene Therapeutics LLC

      • 14.9.1 Errant Gene Therapeutics LLC Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 ArQule Inc

      • 14.10.1 ArQule Inc Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 CRISPR Therapeutics

      • 14.11.1 CRISPR Therapeutics Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

    • 14.12 Daiichi Sankyo Co Ltd

      • 14.12.1 Daiichi Sankyo Co Ltd Company Profile and Recent Development

      • 14.12.2 Market Performance

      • 14.12.3 Product and Service Introduction

    • 14.13 Acceleron Pharma Inc

      • 14.13.1 Acceleron Pharma Inc Company Profile and Recent Development

      • 14.13.2 Market Performance

      • 14.13.3 Product and Service Introduction

    • 14.14 Addmedica SAS

      • 14.14.1 Addmedica SAS Company Profile and Recent Development

      • 14.14.2 Market Performance

      • 14.14.3 Product and Service Introduction

    • 14.15 Global Blood Therapeutics Inc

      • 14.15.1 Global Blood Therapeutics Inc Company Profile and Recent Development

      • 14.15.2 Market Performance

      • 14.15.3 Product and Service Introduction

    • 14.16 bluebird bio Inc

      • 14.16.1 bluebird bio Inc Company Profile and Recent Development

      • 14.16.2 Market Performance

      • 14.16.3 Product and Service Introduction

    • 14.17 Editas Medicine Inc

      • 14.17.1 Editas Medicine Inc Company Profile and Recent Development

      • 14.17.2 Market Performance

      • 14.17.3 Product and Service Introduction

    • 14.18 Gilead Sciences Inc

      • 14.18.1 Gilead Sciences Inc Company Profile and Recent Development

      • 14.18.2 Market Performance

      • 14.18.3 Product and Service Introduction

    • 14.19 Genethon SA

      • 14.19.1 Genethon SA Company Profile and Recent Development

      • 14.19.2 Market Performance

      • 14.19.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 146 Figures and 189 Tables)

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of ARQ-092 from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of BIVV-003 from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of CAL-H from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of CTX-001 from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of DRX-194 from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Sickle Cell Disease Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Sickle Cell Disease Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Sickle Cell Disease Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Sickle Cell Disease Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Sickle Cell Disease Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of ARQ-092

    • Figure Market Size and Growth Rate of BIVV-003

    • Figure Market Size and Growth Rate of CAL-H

    • Figure Market Size and Growth Rate of CTX-001

    • Figure Market Size and Growth Rate of DRX-194

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Sickle Cell Disease Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Sickle Cell Disease Drug by Different End-Users from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Japan Sickle Cell Disease Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Sickle Cell Disease Drug Production by Regions

    • Table Japan Sickle Cell Disease Drug Production Share by Regions

    • Figure Japan Sickle Cell Disease Drug Production Share by Regions in 2014

    • Figure Japan Sickle Cell Disease Drug Production Share by Regions in 2018

    • Figure Japan Sickle Cell Disease Drug Production Share by Regions in 2026

    • Table Japan Sickle Cell Disease Drug Consumption by Regions

    • Table Japan Sickle Cell Disease Drug Consumption Share by Regions

    • Figure Japan Sickle Cell Disease Drug Consumption Share by Regions in 2014

    • Figure Japan Sickle Cell Disease Drug Consumption Share by Regions in 2018

    • Figure Japan Sickle Cell Disease Drug Consumption Share by Regions in 2026

    • Table Hokkaido Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Hokkaido Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Tohoku Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Tohoku Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Tohoku Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Tohoku Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Kanto Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Kanto Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Kanto Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Kanto Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Kanto Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Kanto Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Kanto Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Chubu Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Chubu Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Chubu Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Chubu Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Chubu Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Chubu Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Chubu Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Kinki Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Kinki Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Kinki Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Kinki Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Kinki Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Kinki Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Kinki Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Chugoku Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Chugoku Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Chugoku Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Chugoku Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Shikoku Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Shikoku Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Shikoku Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Shikoku Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Kyushu Sickle Cell Disease Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Sickle Cell Disease Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Sickle Cell Disease Drug Consumption Share by Types in 2014

    • Figure Kyushu Sickle Cell Disease Drug Consumption Share by Types in 2018

    • Figure Kyushu Sickle Cell Disease Drug Consumption Share by Types in 2026

    • Table Kyushu Sickle Cell Disease Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Sickle Cell Disease Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Sickle Cell Disease Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Sickle Cell Disease Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Sickle Cell Disease Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Bristol-Myers Squibb Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Co

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Co

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Co

    • Table Product and Service Introduction of Bristol-Myers Squibb Co

    • Table Company Profile and Development Status of Bioverativ Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bioverativ Inc

    • Figure Sales and Growth Rate Analysis of Bioverativ Inc

    • Figure Revenue and Market Share Analysis of Bioverativ Inc

    • Table Product and Service Introduction of Bioverativ Inc

    • Table Company Profile and Development Status of CSL Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Ltd

    • Figure Sales and Growth Rate Analysis of CSL Ltd

    • Figure Revenue and Market Share Analysis of CSL Ltd

    • Table Product and Service Introduction of CSL Ltd

    • Table Company Profile and Development Status of Calimmune Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calimmune Inc

    • Figure Sales and Growth Rate Analysis of Calimmune Inc

    • Figure Revenue and Market Share Analysis of Calimmune Inc

    • Table Product and Service Introduction of Calimmune Inc

    • Table Company Profile and Development Status of Annexin Pharmaceuticals AB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Annexin Pharmaceuticals AB

    • Figure Sales and Growth Rate Analysis of Annexin Pharmaceuticals AB

    • Figure Revenue and Market Share Analysis of Annexin Pharmaceuticals AB

    • Table Product and Service Introduction of Annexin Pharmaceuticals AB

    • Table Company Profile and Development Status of Bio Products Laboratory Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bio Products Laboratory Ltd

    • Figure Sales and Growth Rate Analysis of Bio Products Laboratory Ltd

    • Figure Revenue and Market Share Analysis of Bio Products Laboratory Ltd

    • Table Product and Service Introduction of Bio Products Laboratory Ltd

    • Table Company Profile and Development Status of Gamida Cell Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gamida Cell Ltd

    • Figure Sales and Growth Rate Analysis of Gamida Cell Ltd

    • Figure Revenue and Market Share Analysis of Gamida Cell Ltd

    • Table Product and Service Introduction of Gamida Cell Ltd

    • Table Company Profile and Development Status of Angiocrine Bioscience Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Angiocrine Bioscience Inc

    • Figure Sales and Growth Rate Analysis of Angiocrine Bioscience Inc

    • Figure Revenue and Market Share Analysis of Angiocrine Bioscience Inc

    • Table Product and Service Introduction of Angiocrine Bioscience Inc

    • Table Company Profile and Development Status of Errant Gene Therapeutics LLC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Errant Gene Therapeutics LLC

    • Figure Sales and Growth Rate Analysis of Errant Gene Therapeutics LLC

    • Figure Revenue and Market Share Analysis of Errant Gene Therapeutics LLC

    • Table Product and Service Introduction of Errant Gene Therapeutics LLC

    • Table Company Profile and Development Status of ArQule Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ArQule Inc

    • Figure Sales and Growth Rate Analysis of ArQule Inc

    • Figure Revenue and Market Share Analysis of ArQule Inc

    • Table Product and Service Introduction of ArQule Inc

    • Table Company Profile and Development Status of CRISPR Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CRISPR Therapeutics

    • Figure Sales and Growth Rate Analysis of CRISPR Therapeutics

    • Figure Revenue and Market Share Analysis of CRISPR Therapeutics

    • Table Product and Service Introduction of CRISPR Therapeutics

    • Table Company Profile and Development Status of Daiichi Sankyo Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd

    • Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd

    • Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd

    • Table Product and Service Introduction of Daiichi Sankyo Co Ltd

    • Table Company Profile and Development Status of Acceleron Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acceleron Pharma Inc

    • Figure Sales and Growth Rate Analysis of Acceleron Pharma Inc

    • Figure Revenue and Market Share Analysis of Acceleron Pharma Inc

    • Table Product and Service Introduction of Acceleron Pharma Inc

    • Table Company Profile and Development Status of Addmedica SAS

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addmedica SAS

    • Figure Sales and Growth Rate Analysis of Addmedica SAS

    • Figure Revenue and Market Share Analysis of Addmedica SAS

    • Table Product and Service Introduction of Addmedica SAS

    • Table Company Profile and Development Status of Global Blood Therapeutics Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Global Blood Therapeutics Inc

    • Figure Sales and Growth Rate Analysis of Global Blood Therapeutics Inc

    • Figure Revenue and Market Share Analysis of Global Blood Therapeutics Inc

    • Table Product and Service Introduction of Global Blood Therapeutics Inc

    • Table Company Profile and Development Status of bluebird bio Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of bluebird bio Inc

    • Figure Sales and Growth Rate Analysis of bluebird bio Inc

    • Figure Revenue and Market Share Analysis of bluebird bio Inc

    • Table Product and Service Introduction of bluebird bio Inc

    • Table Company Profile and Development Status of Editas Medicine Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Editas Medicine Inc

    • Figure Sales and Growth Rate Analysis of Editas Medicine Inc

    • Figure Revenue and Market Share Analysis of Editas Medicine Inc

    • Table Product and Service Introduction of Editas Medicine Inc

    • Table Company Profile and Development Status of Gilead Sciences Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

    • Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

    • Figure Revenue and Market Share Analysis of Gilead Sciences Inc

    • Table Product and Service Introduction of Gilead Sciences Inc

    • Table Company Profile and Development Status of Genethon SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genethon SA

    • Figure Sales and Growth Rate Analysis of Genethon SA

    • Figure Revenue and Market Share Analysis of Genethon SA

    • Table Product and Service Introduction of Genethon SA

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US